Results 261 to 270 of about 37,267 (288)

Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 242-249, July 1, 2025.
ABSTRACT Background Paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) is a complication linked to poor outcomes. The prognostic impact of mild PVR, particularly in patients with elevated preprocedural left ventricular (LV) filling pressure, remains uncertain.
Shumpei Kosugi, Isamu Mizote, Daisuke Nakamura, Hiroki Sugae, Yutaka Matsuhiro, Shota Okuno, Ai Kawamura, Kizuku Yamashita, Koichi Maeda, Kazuo Shimamura, Tomoharu Dohi, Yasuharu Takeda, Yasushi Sakata   +12 more
wiley   +1 more source

A patient with AL amyloidosis presenting with refractory tuberculosis, chest tightness and hypotension: case report. [PDF]

BMC Pulm Med
Yang J, Farhath MFF, Tian H, Yang L, Liu D.   +4 more
europepmc   +1 more source

The Herald Bleed—A Fortunate Endoscopic Diagnosis of an Aorto‐Duodenal Fistula Secondary to a Mycotic Aortic Aneurysm With Abscess Formation

Clinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Aorto‐duodenal fistula is a rare but catastrophic cause of gastrointestinal bleeding. A high index of suspicion is required for diagnosis. Reviewing previous imaging provides essential hints. A pulsatile clot or bleeding source can be seen on endoscopy. Management is surgical with multi‐disciplinary involvement.
Arteen Arzivian, Robert O'Neill, Ian Lockart   +2 more
wiley   +1 more source

Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis. [PDF]

Nat Commun
Schulte T, Chaves-Sanjuan A, Speranzini V, Sicking K, Milazzo M, Mazzini G, Rognoni P, Caminito S, Milani P, Marabelli C, Corbelli A, Diomede L, Fiordaliso F, Anastasia L, Pappone C, Merlini G, Bolognesi M, Nuvolone M, Fernández-Busnadiego R, Palladini G, Ricagno S.   +20 more
europepmc   +1 more source

Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosis. [PDF]

Ann Hematol
Brunger AF, Tingen HSA, Bijzet J, van Rheenen R, Blokzijl H, Roeloffzen WWH, Houwerzijl EJ, Muntinghe FLH, Slart RHJA, Gans ROB, Kimmich C, Hazenberg BPC, Nienhuis HLA.   +12 more
europepmc   +1 more source

A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis. [PDF]

Cancers (Basel)
Ríos-Tamayo R, Lecumberri R, Cibeira MT, González-Calle V, Alonso R, Domingo-González A, Landete E, Encinas C, Iñigo B, Blanchard MJ, Alejo E, Krsnik I, Gómez-Bueno M, Garcia-Pavia P, Segovia-Cubero J, Rosiñol L, Lahuerta JJ, Martínez-López J, Bladé J.   +18 more
europepmc   +1 more source

Correction to "Risk factors for severe infection and mortality in patients with COVID-19 in patients with multiple myeloma and AL amyloidosis". [PDF]

Am J Hematol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunotherapy in AL Amyloidosis

Current Treatment Options in Oncology, 2022
Light-chain amyloidosis is a rare disorder where a small clone of plasma cells is producing excess toxic light chains that deposit in various organs and cause dysfunction. Cardiac involvement is a major determinant of survival and rapid reduction of light chain is critical for recovery of organ function and overall survival. Immunotherapy targeting the
Yifei, Zhang, Raymond L, Comenzo
openaire   +2 more sources

Once AL amyloidosis: not always AL amyloidosis

Amyloid, 2018
Amyloid cardiomyopathy could be related to AL amyloidosis, wild-type transthyretin amyloidosis (ATTRwt) or hereditary amyloidosis (ATTRm).
Tulip Jhaveri, Shayna Sarosiek, Frederick L. Ruberg, Omar Siddiqi, John L. Berk, Vaishali Sanchorawala   +5 more
openaire   +3 more sources